Bio Essence Corporation
BIOE
$0.206
-$0.008-3.74%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 9.58% | 223.02% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.58% | 223.02% | |||
| Cost of Revenue | -24.21% | 329.60% | |||
| Gross Profit | 31.98% | 177.40% | |||
| SG&A Expenses | -54.71% | 17.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -48.88% | 9.80% | |||
| Operating Income | 102.66% | 31.68% | |||
| Income Before Tax | 97.70% | -458.17% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 97.70% | -456.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 97.70% | -456.10% | |||
| EBIT | 102.66% | 31.68% | |||
| EBITDA | 102.80% | 31.59% | |||
| EPS Basic | 97.78% | -454.39% | |||
| Normalized Basic EPS | 79.17% | 31.43% | |||
| EPS Diluted | 97.78% | -454.39% | |||
| Normalized Diluted EPS | 79.17% | 31.43% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||